Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6437123rdf:typepubmed:Citationlld:pubmed
pubmed-article:6437123lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C0278134lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C0002026lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C0015131lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C0015846lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:6437123lifeskim:mentionsumls-concept:C1522673lld:lifeskim
pubmed-article:6437123pubmed:issue5lld:pubmed
pubmed-article:6437123pubmed:dateCreated1984-12-19lld:pubmed
pubmed-article:6437123pubmed:abstractTextThis investigation was designed to study the comparative haemodynamic effects of alfentanil, 5 mg vs. fentanyl 0.5 mg when administered in combination with etomidate for induction of anaesthesia in patients undergoing cardiac surgery. Both groups manifested significant decreases in heart rate (17-22%), cardiac index (12-25%) and mean pulmonary artery pressure (4-17%). The mean arterial pressure was decreased in both groups; however, the decrease was significantly greater in the alfentanil group. In contrast to the fentanyl group, the systemic vascular resistance was transiently decreased in in the alfentanil group. In conclusion, it appears that alfentanil is associated with a greater degree of cardiovascular depression than fentanyl when used in combination with etomidate as part of an induction sequence in cardiac surgery patients.lld:pubmed
pubmed-article:6437123pubmed:languageenglld:pubmed
pubmed-article:6437123pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6437123pubmed:citationSubsetIMlld:pubmed
pubmed-article:6437123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6437123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6437123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6437123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6437123pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6437123pubmed:statusMEDLINElld:pubmed
pubmed-article:6437123pubmed:monthOctlld:pubmed
pubmed-article:6437123pubmed:issn0001-5172lld:pubmed
pubmed-article:6437123pubmed:authorpubmed-author:HaiderWWlld:pubmed
pubmed-article:6437123pubmed:authorpubmed-author:CoraimFFlld:pubmed
pubmed-article:6437123pubmed:authorpubmed-author:SpissC KCKlld:pubmed
pubmed-article:6437123pubmed:authorpubmed-author:WhiteP FPFlld:pubmed
pubmed-article:6437123pubmed:issnTypePrintlld:pubmed
pubmed-article:6437123pubmed:volume28lld:pubmed
pubmed-article:6437123pubmed:ownerNLMlld:pubmed
pubmed-article:6437123pubmed:authorsCompleteYlld:pubmed
pubmed-article:6437123pubmed:pagination554-6lld:pubmed
pubmed-article:6437123pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:meshHeadingpubmed-meshheading:6437123-...lld:pubmed
pubmed-article:6437123pubmed:year1984lld:pubmed
pubmed-article:6437123pubmed:articleTitleHaemodynamic effects of fentanyl or alfentanil as adjuvants to etomidate for induction of anaesthesia in cardiac patients.lld:pubmed
pubmed-article:6437123pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6437123pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed